Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-15-024140)

Filing Details

Accession Number:: 0001209191-15-024140
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-03-09 17:00:38
Reporting Period:: 2015-03-05

Filing Date:: 2015-03-09
Accepted Time:: 2015-03-09 17:00:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1159036	Halozyme Therapeutics Inc	HALO	Biological Products, (No Disgnostic Substances) (2836)	880488686

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1291219	J Kenneth Kelley	C/O Halozyme Therapeutics, Inc. 11388 Sorrento Valley Blvd. San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-03-05	40,000	$15.33	194,876	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.25 to $15.51, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.